Komori
M&A and Subsidiary Changes5187CREATE MEDIC CO.,LTD.Electrical Equipment and Precision Instruments

Notice Regarding the Acquisition of Shares in Globizz Corporation and Other Companies (Making Them Subsidiaries)

CREATE MEDIC CO.,LTD. acquired all issued shares of 4 Globizz Group companies in the United States, Japan and South Korea, making them wholly owned subsidiaries. Through this acquisition, the Company will bring in regulatory compliance and business development capabilities to support entry into the U.S. market and the overseas expansion of its medical device business.

Worth reading
47Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
100
%
Wording
Definitive
How definitive the wording is.

This transaction

This share acquisition
CounterpartyUndisclosed (individual shareholder)
Disclosing companyCREATE MEDIC CO.,LTD.
Globizz Corporation, Universal Design Life Corporation, 株式会社グロービッツ・ジャパン, Globizz Korea Co., Ltd.Subject of this transactionNumber of shares acquired Subject Globizz Corporation / Number of Shares 100 shares / Number of voting rights Not disclosed, Subject Universal Design Life Corporation / Number of Shares 100 shares / Number of voting rights Not disclosed, Subject 株式会社グロービッツ・ジャパン / Number of Shares 30 shares / Number of voting rights Not disclosed, Subject Globizz Korea Co., Ltd. / Number of Shares 100,000 shares / Number of voting rights Not disclosedVoting rights ownership percentage Before －％, －％, －％, －％ → after 100％, 100％, 100％, 100％
TimelineThe spacing between the points is proportional to the actual number of days.
Target company

Globizz Corporation Consulting, Universal Design Life Corporation Medical device sales, 株式会社グロービッツ・ジャパン Consulting services covering the healthcare business in general, Globizz Korea Co., Ltd. Consulting

Location Globizz Corporation 970 W. 190th St. Suite 200 Torrance, California 90502 U.S.A., Universal Design Life Corporation 970 W. 190th St. Suite 200 Torrance, California 90502 U.S.A., 株式会社グロービッツ・ジャパン 1-9-2 Otemachi, Chiyoda-ku, Tokyo, Global Business Hub Tokyo, Globizz Korea Co., Ltd. KOTRA Invest Korea Plaza, Building 7, Heolleung-ro, Seocho-gu, Seoul, KoreaShare capital Globizz Corporation USD 100,000, Universal Design Life Corporation USD 10,000, 株式会社グロービッツ・ジャパン ¥3 million, Globizz Korea Co., Ltd. KRW 100,000,000Date of incorporation Globizz Corporation 16 May 2005, Universal Design Life Corporation 8 August 2013, 株式会社グロービッツ・ジャパン 4 June 2014, Globizz Korea Co., Ltd. 8 October 2024
Consideration and expenses
Acquisition priceAs the shareholder is an individual, the acquisition price is undisclosed due to the confidentiality obligations under the share transfer agreement. The shares were acquired at a price calculated using a fair method following appropriate due diligence.
Impact on Business Performance

The impact of this share acquisition on the consolidated results of the Company's group for the current fiscal year is immaterial. The Company will promptly disclose any matters requiring disclosure if they arise.

Procedures and assumptions
Valuation methodologyAn amount calculated using a fair method following appropriate due diligence
This transaction
ItemDetails
Transaction nameThis share acquisition
Counterparty nameUndisclosed (individual shareholder)
Name of the Subject CompanyGlobizz Corporation, Universal Design Life Corporation, 株式会社グロービッツ・ジャパン, Globizz Korea Co., Ltd.
Business Description of the Subject CompanyGlobizz Corporation Consulting, Universal Design Life Corporation Medical device sales, 株式会社グロービッツ・ジャパン Consulting services covering the healthcare business in general, Globizz Korea Co., Ltd. Consulting
Location of the Subject CompanyGlobizz Corporation 970 W. 190th St. Suite 200 Torrance, California 90502 U.S.A., Universal Design Life Corporation 970 W. 190th St. Suite 200 Torrance, California 90502 U.S.A., 株式会社グロービッツ・ジャパン 1-9-2 Otemachi, Chiyoda-ku, Tokyo, Global Business Hub Tokyo, Globizz Korea Co., Ltd. KOTRA Invest Korea Plaza, Building 7, Heolleung-ro, Seocho-gu, Seoul, Korea
Capital Stock of the Subject CompanyGlobizz Corporation USD 100,000, Universal Design Life Corporation USD 10,000, 株式会社グロービッツ・ジャパン ¥3 million, Globizz Korea Co., Ltd. KRW 100,000,000
Date of Establishment of the Subject CompanyGlobizz Corporation 16 May 2005, Universal Design Life Corporation 8 August 2013, 株式会社グロービッツ・ジャパン 4 June 2014, Globizz Korea Co., Ltd. 8 October 2024
Acquisition priceAs the shareholder is an individual, the acquisition price is undisclosed due to the confidentiality obligations under the share transfer agreement. The shares were acquired at a price calculated using a fair method following appropriate due diligence.
Number of shares acquiredSubject Globizz Corporation / Number of Shares 100 shares / Number of voting rights Not disclosed, Subject Universal Design Life Corporation / Number of Shares 100 shares / Number of voting rights Not disclosed, Subject 株式会社グロービッツ・ジャパン / Number of Shares 30 shares / Number of voting rights Not disclosed, Subject Globizz Korea Co., Ltd. / Number of Shares 100,000 shares / Number of voting rights Not disclosed
Voting rights ownership percentageBefore －％, －％, －％, －％ → after 100％, 100％, 100％, 100％
Impact on Business PerformanceThe impact of this share acquisition on the consolidated results of the Company's group for the current fiscal year is immaterial. The Company will promptly disclose any matters requiring disclosure if they arise.
Date of board resolution7 October 2026
Contract Date9 October 2026
Execution Date / Effective Date14 October 2026 (completion of the share transfer)
Valuation methodologyAn amount calculated using a fair method following appropriate due diligence
Items this document does not state (17)
Net Sales of the Subject CompanyOperating Profit of the Subject CompanyNet Income of the Subject CompanyNet Assets of the Subject CompanyExpenses other than the acquisition priceType of ConsiderationMerger ratio/share exchange ratioTender offer priceMinimum number of shares to be purchasedTender offer periodFunding arrangementsGoodwill amountAmount of extraordinary income (loss)Independent valuation institutionSpecial CommitteeConditions Precedent to ExecutionManagement structure after acquisition

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The acquisition is intended to bring in the FDA-related capabilities required to enter the U.S. market, market research and business strategy capabilities for overseas expansion, as well as human resources and a customer base. The Company aims to strengthen its overseas business by combining entry into the U.S. market, the introduction of overseas products into the Japanese and Asian markets, and the expansion of the Globizz Group's business.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Acquisition of Shares in Globizz Corporation and Other Companies (Making Them Subsidiaries) | CREATE MEDIC CO.,LTD. (5187) timely disclosure | Komori